Paul Baldrick
- Pharmaceutical Science top 2%
- Small Animals top 2%
- Animal testing and alternatives 18
- Immunology and Allergy top 5%
- Allergic Rhinitis and Sensitization 6
- Biomaterials top 5%
- Immunology top 10%
- Immunotoxicology and immune responses 10
- Biosimilars and Bioanalytical Methods 9
-
- Pharmaceutical studies and practices 8
-
- Carcinogens and Genotoxicity Assessment 6
-
- Computational Drug Discovery Methods 6
-
- Pharmacogenetics and Drug Metabolism 5
- Co-authors
- A.W. WheelerLesley ReevePaul HepburnJ.H. AnsteeGary ElliottLinda J. LeaAlison WolfreysStefan R. Woroniecki
- Journals
- Biochimica et Biophysica Acta (BBA) - Biomembranes (1 paper)Food and Chemical Toxicology (4 papers)Vaccine (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Paul Baldrick
57 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Pharmaceutical Science 196
- Small Animals 158
- Immunology and Allergy 118
- Biomaterials 241
- Immunology 286
Countries citing papers authored by Paul Baldrick
This map shows the geographic impact of Paul Baldrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Baldrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Baldrick more than expected).
Fields of papers citing papers by Paul Baldrick
This network shows the impact of papers produced by Paul Baldrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Baldrick. The network helps show where Paul Baldrick may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul Baldrick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 7 | |
| 5 | 2018 | 8 | |
| 6 | 2017 | 13 | |
| 7 | 2017 | 9 | |
| 8 | 2016 | 28 | |
| 9 | 2015 | 2 | |
| 10 | 2014 | 6 | |
| 11 | 2011 | 4 | |
| 12 | 2010 | 30 | |
| 13 | 2010 | 32 | |
| 14 | The safety of chitosan as a pharmaceutical excipientbreakdown → | 2009 | 443 |
| 15 | 2005 | 30 | |
| 16 | 2004 | 16 | |
| 17 | 2002 | 60 | |
| 18 | 2001 | 8 | |
| 19 | 2001 | 5 | |
| 20 | 1997 | 36 |
About Paul Baldrick
Paul Baldrick is a scholar working on Chemical Health and Safety, Small Animals and Immunology and Allergy, having authored 59 papers that have together received 1.5k indexed citations. Recurring topics across this work include Animal testing and alternatives (18 papers), Immunotoxicology and immune responses (10 papers), Biosimilars and Bioanalytical Methods (9 papers), Pharmaceutical studies and practices (8 papers), Allergic Rhinitis and Sensitization (6 papers), Carcinogens and Genotoxicity Assessment (6 papers), Computational Drug Discovery Methods (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). The work is most often cited by research in Pharmaceutical Science (196 citations), Small Animals (158 citations) and Immunology and Allergy (118 citations). Paul Baldrick has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include A.W. Wheeler, Lesley Reeve, Paul Hepburn, J.H. Anstee, Gary Elliott, Linda J. Lea, Alison Wolfreys, Stefan R. Woroniecki, David Hyde and Kathryn Chapman. Their work appears in journals such as Biochimica et Biophysica Acta (BBA) - Biomembranes, Food and Chemical Toxicology and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.